Search Results - "Rittenhouse, B." :: K.UTB vyhledávací portál

by CHOINIERE, M, RITTENHOUSE, B. E, PERREAULT, S, CHARTRAND, D, ROUSSEAU, P, SMITH, B, PEPLER, C
Published in Anesthesiology (Philadelphia) (01.12.1998)

Get full text

Journal Article

Loading…

EE453 The Singapore Diabetes Prevention Program Cost-Effectiveness Analysis Revisited: Proper Methods Overturn Previous Conclusions

by Paredes, J, Rittenhouse, B
Published in Value in health (01.07.2022)

Get full text

Journal Article

Loading…

P45 Visualizing Joint Costs and Effects for Multiple Alternatives within Cost Effectiveness Analyses: Cost-Disutility Versus Traditional Cost-Effectiveness Planes in an Economic Evaluation of Opioid Use Disorder Treatments

by Beaulieu, E., Rittenhouse, B.
Published in Value in health (01.07.2022)

Get full text

Journal Article

Loading…

EE358 Transparency and Utility of Using Net Monetary Benefit (NMB) Analysis over Incremental Cost-Effectiveness Ratios (ICERS): The Case of the Singapore Diabetes Prevention Program Cost-Effectiveness Analysis (CEA)

by Paredes, J, Rittenhouse, B
Published in Value in health (01.07.2022)

Get full text

Journal Article

Loading…

EE234 Advantages of Visualizing Net Loss Curves in Cost Effectiveness Analyses: An Example Comparing Opioid Use Disorder Treatment Alternatives

by Beaulieu, E, Rittenhouse, B
Published in Value in health (01.07.2022)

Get full text

Journal Article

Loading…

PMD94 - Accounting for Known Unknowns in the American College Of Medical Genetics (ACMG) Recommendations for NBS: Policy Implications of Accounting for Uncertainty in Assessment in the Case of Medium Chain Ketoacyl-COA Thiolase Deficiency (MCKAT) Newborn Screening (NBS)

by Rittenhouse, B
Published in Value in health (01.05.2018)

Get full text

Journal Article

Loading…

Accounting for Known Unknowns in the American College Of Medical Genetics (ACMG) Recommendations for NBS: Policy Implications of Accounting for Uncertainty in Assessment in the Case of Medium Chain Ketoacyl-COA Thiolase Deficiency (MCKAT) Newborn Screening (NBS)

by Rittenhouse, B
Published in Value in health (01.05.2018)

Get full text

Journal Article

Loading…

PMH12 Medications for Opioid Use Disorder: The Advantage of Office-Administered Methadone in a Cost-Effectiveness Framework

by Beaulieu, E., Rittenhouse, B.
Published in Value in health (01.12.2020)

Get full text

Journal Article

Loading…

PMH43 Difference in Precision of Retention Estimates for Mandated Versus Patient-Chosen Medication-Assisted Treatment (MAT) Alternatives for Opioid Use Disorder (OUD)

by Rittenhouse, B., Beaulieu, E.
Published in Value in health (01.12.2020)

Get full text

Journal Article

Loading…

PMD162 - AMERICAN COLLEGE OF MEDICAL GENETICS (ACMG) NEWBORN SCREENING (NBS) RECOMMENDATIONS: SENSITIVITY TO ACCOUNTING FOR REPORTED MISSING DATA IN THE CASE OF GLUTARIC ACIDURIA II (GAII)

by Algarni, M., Rittenhouse, B.
Published in Value in health (01.10.2018)

Get full text

Journal Article

Loading…

Examining the Effect of Missing Data on the Acmg Newborn Screening Criteria of Least Consensus for Carnitine Palmitoyltransferase II Deficiency (CPTII)

by Redlich, A, Rittenhouse, B
Published in Value in health (01.05.2018)

Get full text

Journal Article

Loading…

PHS85 - Examining the Effect of Missing Data on the Acmg Newborn Screening Criteria of Least Consensus for Carnitine Palmitoyltransferase II Deficiency (CPTII)

by Redlich, A, Rittenhouse, B
Published in Value in health (01.05.2018)

Get full text

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database